newsfilter
← Latest News
Business Wire·

Forte Biosciences Announces Proposed Public Offering

Forte Biosciences, Inc. (NASDAQ:FBRX), a clinical-stage biopharmaceutical company focused on autoimmune and autoimmune-related diseases, today announced that it has commenced an underwritten public offering of shares of